Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

 SummaryNewsCalendarCompanyFinancials 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases.The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial against... 
More about the company
Latest news on CEL-SCI CORPORATION
07/22 CEL SCI CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
07/11 CEL SCI : NEW STORY CEL-SCI Granted European Patent for Multikine Cancer Immunot..
07/11 CEL SCI : Granted European Patent for Multikine Cancer Immunotherapy in Combinat..
07/05 CEL SCI : NEW STORY CEL-SCI Reports Monthly Patient Enrollment in June for Its P..
07/05 CEL SCI : Reports Monthly Patient Enrollment in June for Its Phase 3 Head and Ne..
06/09 CEL SCI : to Present at the Fifth Annual Marcum MicroCap Conference
06/07 CEL SCI : NEW STORY CEL-SCI to Present at LD Micro Invitational
06/07 CEL SCI : to Present at LD Micro Invitational
06/02 CEL SCI : Announces the Closing of Its $5 Million Registered Direct Offering
06/01 CEL SCI : NEW STORY CEL-SCI Reports Monthly Patient Enrollment in May for Its Ph..
More news
Sector news : Bio Therapeutic Drugs
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Geert R. Kersten CEO, CFO, Treasurer, Director & CAO
Maximilian de Clara President & Director
Patricia B. Prichep Secretary & Senior Vice President-Operations
Eyal Talor Chief Scientific Officer
Alexander G. Esterhazy Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CEL-SCI CORPORATION61
AMGEN, INC.2.06%124 454
GILEAD SCIENCES, INC.-14.47%115 269
CELGENE CORPORATION-10.22%83 285
REGENERON PHARMACEUTIC..-27.91%41 121
VERTEX PHARMACEUTICALS..-25.38%23 224
More Results